Condition
Age Related Macular Degeneration
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 18 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
18 shownHigh Resolution Imaging OCT StudyNCT07338461 · 2026-03-13
RECRUITINGStrategies for Improving Linkage-to-Care After Eye Disease ScreeningNCT06943599 · 2026-02-01
RECRUITINGEffect of Video Viewing on Intravitreal Injection ExperienceNCT07002372 · 2025-05-05
RECRUITINGEvaluating a New Peptide Therapy for Retinal Diseases: AMD, Diabetic Retinopathy, and DystrophiesNCT06787482 · 2024-11-12
RECRUITINGAI-Assisted Detection of Posterior Segment Diseases: DR, AMD, RVO, and GlaucomaNCT07318428 · 2026-02-20
COMPLETEDAn Interpretable Fundus Diseases Report Generating System Based On Weakly LabelingsNCT06918028 · 2025-05-01
NOT_YET_RECRUITINGRetinal Care Data RepositoryNCT04794907 · 2022-12-31
NOT_YET_RECRUITINGMitochondrial DNA in Vitreous Fluid and Blood in Patients With Eye Disease or Ocular Trauma.NCT04334499 · 2020-02-21
WITHDRAWNAssociation Between Age-related Macular Degeneration and Cognitive Impairment Based on Exosome ProteomicsNCT06883461 · 2019-04-01
COMPLETEDAssessment of Visual Function With a Portable Brain-computer InterfaceNCT03760055 · 2019-02-11
UNKNOWNVillage-Integrated Eye Worker Trial II - PilotNCT03278587 · 2018-05-31
COMPLETEDPrevalence of Age Related Macular Degeneration (ARMD) in Parkinson's Patients and Assesment of the Role of L-DOPANCT03415984 · 2018-01-19
COMPLETEDReading Analysis in Ophthalmologic PatientsNCT03750149 · 2018-01-01
UNKNOWNPolarization Perception in Health and Disease. Testing a New Sight TestNCT03823092 · 2017-11-09
UNKNOWNSmartphone Screening for Eye DiseasesNCT03076697 · 2015-04-16
COMPLETEDProspective Study Phase: Retinal Oxygen Saturation, Blood Flow, Vascular Function and High Resolution Morphometric Imaging in the Living Human EyeNCT01348672 · 2012-03-01
UNKNOWNAssociation Between Light Spectrum and Survival After Cataract SurgeryNCT04187157 · 2012-01-01
COMPLETEDOral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis for Ocular Hypertension Control After Intravitreal BevacizumabNCT00864838 · 2008-06-01
COMPLETEDCommon interventions
ACE RetinoDIETARY_SUPPLEMENT1AcetazolamideDRUG1Anterior chamber paracentesisPROCEDURE1Autofluorescence ImagingDEVICE1Blue-light filtering intraocular lensDEVICE1Brimonidine tartarateDRUG1Cataract camp programOTHER1Color retinographyDIAGNOSTIC_TEST1Community health worker programOTHER1Community-based screening programOTHER1Conventional intraocular lensDEVICE1EyeTrackerDEVICE1Fundus autofluorescence imagingDIAGNOSTIC_TEST1Fundus photographyDIAGNOSTIC_TEST1Health Worker VisitOTHER1Infrared reflectance imagingDEVICE1nGoggleDEVICE1ObservationOTHER1OCT imagingDEVICE1OCTA imagingDEVICE1Optical coherence tomographyDIAGNOSTIC_TEST1polarization sensitivityDIAGNOSTIC_TEST1Procedure video viewingBEHAVIORAL1Sample collection from tissue discardOTHER1Text Message ReminderOTHER1
Leading sponsors
University of California, San Francisco
2
Ace Cells Lab Limited
1
Fondation Ophtalmologique Adolphe de Rothschild
1
Heidelberg Engineering GmbH
1
Inje University
1
NGoggle
1
Prim. Prof. Dr. Oliver Findl, MBA
1
Retinal Care Inc.
1
Second Affiliated Hospital, Zhejiang University, School of Medicine
1
Shanghai 10th People's Hospital
1
South Warwickshire NHS Foundation Trust
1
The University of Texas Medical Branch, Galveston
1
University of Michigan
1
University of Pittsburgh
1
University of Sao Paulo
1
Trial status mix
COMPLETED7
RECRUITING4
UNKNOWN4
NOT_YET_RECRUITING2
WITHDRAWN1
Phase mix
NA6
PHASE22
PHASE11
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.